Gene Expression Market Analysis

Gene Expression Market Analysis

To get key market trends

  Download Free Sample

Based on the process, the market is classified into sample collection, purification, cDNA synthesis & conversion, PCR analysis, and data analysis & interpretation. The data analysis & interpretation segment is set to expand at a CAGR of 7.8% through 2032.

• The segmental growth is majorly attributable to the substantial investments in research focused on cancer and the rising need for sophisticated interpretation software tailored for studies involving cancer gene expression. Diverse methodologies and algorithms are currently under development to investigate gene expression patterns in complex conditions such as cancer. For instance, techniques like projective clustering and ensemble methods are being utilized to integrate data from cancer gene expression studies effectively.

Based on product, the gene expression market is classified into consumables, instruments, and services. Consumables segment is further sub segmented into reagents and DNA chips. Instruments are further bifurcated into polymerase chain reaction, next generation sequencing, DNA microarray and other instruments. Consumables segment accounted for 46.9% of the market share in 2023.

• Consumables encompass a range of products, including RNA extraction kits, PCR reagents, reverse transcription reagents, sequencing libraries, fluorescent dyes and probes, and other assay components essential for gene expression analysis. They are commonly utilized in gene expression experiments and are typically tailored to specific techniques or platforms. Consumables steady and regular use creates a stable market base, that supports their dominance in the market.

   

Based on application, the gene expression market is classified into drug discovery & development, clinical diagnostics, biotech & microbiology, and other applications. The drug discovery & development segment is expected to hold the highest revenue throughout the forecast period.

• Gene expression profiling have become an integral drug discovery technique for pharmaceutical companies. The effectiveness, toxicity, and other features of pharmaceuticals are assessed through monitoring the activity of a cell's genes in response to drugs.

   

• Additionally, the integration of advanced technologies, interdisciplinary collaborations, and a focus on precision medicine are projected to drive the segmental growth.

   

Based on techniques, the gene expression market is classified into RNA expression, promoter analysis, and protein expression & posttranslational modification analysis. Promoter analysis segment is predicted to witness 7.4% CAGR during 2024 to 2032.

• Promoter analysis is critical for understanding gene expression regulation and identifying significant factors that influence gene activity. It is the initial step in the computational investigation that leads to the prediction of regulatory variables.

   

• Therefore, contribution of promoter analysis in gene regulation and its growing applications in various fields including functional genomics, drug development, and disease biomarker discovery is anticipated to accelerate the market growth.

   

Based on capacity, the gene expression market is classified into low- to mid- plex and high-plex. The high-plex segment dominated around USD 8.4 billion revenue in 2023.

• It typically involves the analysis of thousands of genes, or a sizable number of gene targets. In gene expression analysis, high-plex technologies include microarrays and RNA sequencing.

   

• In addition, high-plex analysis requires less hands-on time than other standard methods like qPCR. This technique is also remarkably precise and straightforward since it eliminates the need for initial probe validation. The advancement of spatially resolved, multiplexed digital characterization systems additionally impel the segmental growth.

   

Based on end-user, the gene expression market is classified into academic and research institute, pharmaceutical and biotechnology companies, diagnostic centers, and other end-users. The academic and research institute segment is set to hold the highest revenue throughout the forecast period.

• Academic and research institutes effectively utilize gene expression analysis to advance scientific knowledge and contribute to advancements in various fields, including medicine, biotechnology, and agriculture.

   

• Further, encouraging interdisciplinary collaboration within the institute and establishing partnerships with other academic and research institutions is anticipated to accelerate the innovation and discoveries in various fields.

North America secured a substantial market size held over USD 5.3 billion in 2023.

• The factors such as the increased funding from government agencies, private investors, and pharmaceutical companies’ fuels innovation in gene expression technologies and applications contributes significantly to the market's growth over the projection period.

   

• For instance, in August 2022, the Department of Health and Human Services issued a funding opportunity announcement (FOA) for novel research and study of structural birth defects using human translational/clinical approaches and animal models. The FOA covered several research areas, including the identification of connected modifier genes that influence the variation and vulnerability of structural birth defects gene expression, as well as the study of altered gene expression, epigenetic factors, and imprinting.

   

• Thus, aforementioned factors are anticipated to accelerate the regional market growth.